Ji-yan Chen

659 total citations
34 papers, 428 citations indexed

About

Ji-yan Chen is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ji-yan Chen has authored 34 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 13 papers in Cardiology and Cardiovascular Medicine and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ji-yan Chen's work include Infective Endocarditis Diagnosis and Management (12 papers), Streptococcal Infections and Treatments (10 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Ji-yan Chen is often cited by papers focused on Infective Endocarditis Diagnosis and Management (12 papers), Streptococcal Infections and Treatments (10 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Ji-yan Chen collaborates with scholars based in China, United States and Australia. Ji-yan Chen's co-authors include Danqing Yu, Xuebiao Wei, Shen‐Ming Chen, Vairathevar Sivasamy Vasantha, Pengcheng He, Ning Tan, Liu Y, Yingling Zhou, Yigao Huang and Tsung O. Cheng and has published in prestigious journals such as New England Journal of Medicine, Scientific Reports and Electrochimica Acta.

In The Last Decade

Ji-yan Chen

33 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ji-yan Chen China 12 156 149 125 61 53 34 428
Xiaozhu Liu China 12 89 0.6× 75 0.5× 52 0.4× 23 0.4× 70 1.3× 57 461
Jingang Yang China 15 72 0.5× 306 2.1× 90 0.7× 21 0.3× 26 0.5× 53 588
Navaid Iqbal United States 12 98 0.6× 346 2.3× 116 0.9× 20 0.3× 75 1.4× 18 666
Katalin Keltai Hungary 6 20 0.1× 219 1.5× 256 2.0× 34 0.6× 113 2.1× 15 463
D. Rajasekhar India 14 91 0.6× 232 1.6× 105 0.8× 36 0.6× 101 1.9× 75 529
D. van der Voort Netherlands 9 52 0.3× 93 0.6× 42 0.3× 8 0.1× 35 0.7× 10 339
Devin W. Kehl United States 7 58 0.4× 155 1.0× 139 1.1× 11 0.2× 46 0.9× 13 328
David Nathan United States 5 63 0.4× 39 0.3× 77 0.6× 31 0.5× 30 0.6× 9 552
Jie Han China 16 78 0.5× 412 2.8× 131 1.0× 11 0.2× 34 0.6× 66 685
Yusi Chen China 10 69 0.4× 113 0.8× 53 0.4× 17 0.3× 31 0.6× 41 413

Countries citing papers authored by Ji-yan Chen

Since Specialization
Citations

This map shows the geographic impact of Ji-yan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji-yan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji-yan Chen more than expected).

Fields of papers citing papers by Ji-yan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji-yan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji-yan Chen. The network helps show where Ji-yan Chen may publish in the future.

Co-authorship network of co-authors of Ji-yan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ji-yan Chen. A scholar is included among the top collaborators of Ji-yan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji-yan Chen. Ji-yan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tian, Zhiqi, et al.. (2024). Prevalence of overweight/obesity, and associated factors among adolescents aged 12 ∼ 15 in Shandong Province, China: A cross-sectional study. Preventive Medicine Reports. 45. 102831–102831. 1 indexed citations
2.
Wei, Xuebiao, Yi‐Wei Xu, Yang Li, et al.. (2023). ASSESS-IE: a Novel Risk Score for Patients with Infective Endocarditis. Journal of Cardiovascular Translational Research. 17(3). 695–704. 3 indexed citations
3.
Tong, Guang, Hualin Fan, Lin Zeng, et al.. (2023). Exendin-4 alleviates myocardial ischemia reperfusion injury by enhancing autophagy through promoting nuclear translocation of TFEB. Experimental Cell Research. 423(2). 113469–113469. 13 indexed citations
4.
Yang, Junqing, Jie Li, Qi Zhong, et al.. (2022). A Risk Stratification Scheme for In-Hospital Cardiogenic Shock in Patients With Acute Myocardial Infarction. Frontiers in Cardiovascular Medicine. 9. 793497–793497. 1 indexed citations
5.
Wei, Xuebiao, et al.. (2022). Prevalence and Prognostic Significance of Malnutrition in Hypertensive Patients in a Community Setting. Frontiers in Nutrition. 9. 822376–822376. 14 indexed citations
6.
Wei, Xuebiao, et al.. (2022). Pathophysiologic Basis and Diagnostic Approaches for Ischemia With Non-obstructive Coronary Arteries: A Literature Review. Frontiers in Cardiovascular Medicine. 9. 731059–731059. 17 indexed citations
7.
Huang, Yuqing, Xiaocong Liu, Lin Liu, et al.. (2021). A U-Shaped Relationship Between Selenium Concentrations and All-Cause or Cardiovascular Mortality in Patients With Hypertension. Frontiers in Cardiovascular Medicine. 8. 671618–671618. 21 indexed citations
8.
9.
Wei, Xuebiao, et al.. (2021). The effect of preoperative statin treatment on acute kidney injury in elderly patients undergoing valve replacement surgery. European Journal of Clinical Pharmacology. 78(3). 505–512. 2 indexed citations
10.
Wei, Xuebiao, et al.. (2019). Effect of conjugated bilirubin on clinical outcomes in infective endocarditis. European Journal of Clinical Microbiology & Infectious Diseases. 38(12). 2259–2266. 4 indexed citations
11.
Han, Yaling, Ji-yan Chen, Vijay Chopra, et al.. (2019). ODYSSEY EAST: Alirocumab efficacy and safety vs ezetimibe in high cardiovascular risk patients with hypercholesterolemia and on maximally tolerated statin in China, India, and Thailand. Journal of clinical lipidology. 14(1). 98–108.e8. 35 indexed citations
12.
He, Pengcheng, Xuebiao Wei, Danqing Yu, et al.. (2018). Risk prediction in infective endocarditis by modified MELD-XI score. European Journal of Clinical Microbiology & Infectious Diseases. 37(7). 1243–1250. 11 indexed citations
14.
Wei, Xuebiao, Xiaojin Chen, Danqing Yu, et al.. (2017). Apolipoprotein A-I: A favorable prognostic marker in infective endocarditis. Journal of clinical lipidology. 12(2). 498–505. 6 indexed citations
15.
Wei, Xuebiao, Lei Jiang, Liu Y, et al.. (2017). Serum uric acid as a simple risk factor in patients with rheumatic heart disease undergoing valve replacement surgery. Clinica Chimica Acta. 472. 69–74. 5 indexed citations
16.
Wei, Xuebiao, Liu Y, Pengcheng He, et al.. (2016). The relationship between albuminuria and poor clinical outcomes in patients with infective endocarditis. Clinica Chimica Acta. 462. 28–32. 4 indexed citations
17.
Wei, Xuebiao, Liu Y, Pengcheng He, et al.. (2016). The impact of admission neutrophil-to-platelet ratio on in-hospital and long-term mortality in patients with infective endocarditis. Clinical Chemistry and Laboratory Medicine (CCLM). 55(6). 899–906. 23 indexed citations
18.
Jiang, Lei, Pengcheng He, Yong Liu, et al.. (2015). Mechanism of IFN-γ in regulating OPN/Th17 pathway during vascular collagen remodeling of hypertension induced by ANG II.. PubMed. 8(11). 14433–40. 4 indexed citations
19.
Yu, Danqing, Ji-yan Chen, Ling Xue, et al.. (2011). Effect of atorvastatin therapy on borderline vulnerable lesions in patients with acute coronary syndrome. Archives of Medical Science. 3(3). 433–439. 12 indexed citations
20.
Cheng, Tsung O., et al.. (1996). Percutaneous Balloon Valvuloplasty for Pulmonic Stenosis in Adolescents and Adults. New England Journal of Medicine. 335(1). 21–25. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026